Ezb Myc Diffuse Large B Cell Lymphoma Cn377569
This is a rare, aggressive lymphoma subtype with specific genetic features affecting the MYC gene. Treatment often involves intensive chemotherapy protocols and close monitoring for response.
Key facts at a glance
- ICD-10
- C80.1
- ICD-11
- 2A00.0
- Body system
- oncologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Rapidly enlarging lymph nodes
Bone marrow involvement
Generalized symptoms
(oncologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
B symptoms
(oncologic)Fatigue
(oncologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Drug therapy and clinical monitoring
Active treatment with regular monitoring by a healthcare provider is recommended.
Intensive immunochemotherapy
DA-EPOCH-R or similar dose-adjusted regimens may be preferred given the high-risk nature of EZB-MYC double-hit lymphoma, incorporating etoposide and more intensive dosing.
Additional treatment options
BTK inhibitor-based regimens
Novel targeted therapy options using Bruton tyrosine kinase inhibitors, either as monotherapy or combined with other agents for relapsed disease.
medicationCAR T-cell therapy
Autologous T-cells engineered to target lymphoma cells, representing a transformative approach for relapsed or refractory disease.
procedureDiagnostic biopsy and staging procedures
Minimally invasive biopsies for tissue diagnosis and surgical procedures for central line placement for chemotherapy administration.
surgicalWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Ezb Myc Diffuse Large B Cell Lymphoma Cn377569?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Ezb Myc Diffuse Large B Cell Lymphoma Cn377569. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy